The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarclo Regulatory News (CAR)

Share Price Information for Carclo (CAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11.80
Bid: 12.10
Ask: 13.00
Change: 0.80 (6.81%)
Spread: 0.90 (7.438%)
Open: 12.50
High: 12.50
Low: 11.80
Prev. Close: 11.75
CAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

4 Jul 2019 07:00

RNS Number : 4298E
Carclo plc
04 July 2019
 

4 July 2019

Carclo plc ("Carclo" or the "Group")

Update and directorate change

 

Carclo plc ("Carclo" or the "Group"), a global manufacturer of fine tolerance injection moulded plastic parts mainly for the medical, automotive lighting and optics markets, issues the following update ahead of announcing its results, for the year-ended 31 March 2019, on 23 July 2019.

As announced on 11 June 2019, Wipac is working with its customers to implement a plan to refocus the operation on its historic low-volume high-end vehicle markets where it had previously been financially successful. This strategy is likely to result in a non-cash write down of some project assets in the accounts for the year ending 31 March 2019 and work is currently ongoing to quantify the amount of the write down.

As well as managing the smooth exit of certain programmes, which will significantly reduce the Group's cash requirements for working capital and capital expenditure, a detailed plan is being put in place to turn around the financial and operational performance of the ongoing Wipac business. The plan has two major elements to it: customer support and operational self-help. The objective of this plan is to return Wipac to a position of profitability and cash generation over the next 18 months. Today the Wipac business is incurring significant losses.

Whilst the Group has been preparing this plan it has received a number of approaches from parties, both trade and financial, interested in the potential acquisition of Wipac. Discussions with these parties are at an early stage and there is no certainty that a sale of Wipac will occur.

The Aerospace and Technical Plastics Divisions continue to perform slightly ahead of expectations for the current financial year.

Separately, Sarah Matthews-DeMers, Carclo Group CFO, has informed the Board that she will be leaving the Group at the end of October to take up a similar role with a growing AIM listed company. A search for her replacement will commence shortly. The search continues for a permanent Group CEO, a role which has been filled on a temporary basis by Mark Rollins, Chairman, since the middle of January this year.

As previously announced, discussions remain ongoing with the bank, pension trustee and other stakeholders in relation to the extension of the Group's borrowing facilities, which are currently due to mature in March 2020. During the past week, Wipac has received Euro 8.7m for outstanding tooling balances from its customers. This money has been used to pay suppliers and to fund an expiring short-term £2.0m overdraft facility. As part of the ongoing discussions, the March net debt to EBITDA banking covenant test has again been deferred by the bank, this time until 31 July 2019.

 

Certain information contained in this announcement would have constituted inside information (as defined by Article 7 of Regulation (EU) No 596/2014) ("MAR") prior to its release as part of this announcement and is disclosed in accordance with the Company's obligations under Article 17 of those Regulations.

 

Enquiries:

Carclo plc 01924 268040

Mark Rollins - Executive Chairman

Sarah Matthews-DeMers - Finance Director

 

FTI Consulting 020 3727 1340Nick Hasell / Susanne Yule

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAUGURAMUPBGRW
Date   Source Headline
30th Apr 20247:00 amRNSHolding(s) in Company
30th Apr 20247:00 amRNSHolding(s) in Company
26th Apr 20247:00 amRNSTrading Statement
17th Apr 20247:55 amRNSDirectorate Change
15th Apr 20243:55 pmRNSHolding(s) in Company
28th Feb 20247:00 amRNSDirectorate Change
14th Feb 20247:00 amRNSStrategic Consolidation & Tucson Facility Closure
9th Feb 20241:15 pmRNSHolding(s) in Company
29th Jan 202411:09 amRNSDirectorate Change
23rd Jan 20244:48 pmRNSHolding(s) in Company
6th Dec 202310:53 amRNSHolding(s) in Company
30th Nov 20237:00 amRNSHalf-year Report
16th Nov 20237:00 amRNSNotice of Interim Results & Investor Presentation
25th Oct 20233:16 pmRNSCarclo Strategic Decision to Close Derry Facility
22nd Sep 20237:00 amRNSDirector/PDMR Shareholding
31st Aug 20234:01 pmRNSResult of AGM
31st Aug 20237:00 amRNSTrading Update
21st Aug 20231:09 pmRNSDirectorate Change
31st Jul 202311:42 amRNSAnnual Financial Report
18th Jul 20237:00 amRNSBanking covenant update
12th Jul 20237:00 amRNSFinal Results
7th Jul 20237:00 amRNSNotice of Investor Meet Presentation
23rd Jun 20237:00 amRNSBanking covenant adjustment
21st Jun 20231:08 pmRNSNotice of Results
30th May 202310:07 amRNSUpdate on contract cancellation
17th May 20238:46 amRNSHolding(s) in Company
12th May 20239:38 amRNSHolding(s) in Company
14th Apr 20237:00 amRNSTrading Statement
31st Mar 202312:50 pmRNSBanking Covenant update
9th Mar 20239:56 amRNSHolding(s) in Company
24th Feb 20237:00 amRNSDirectorate Change
6th Jan 20234:17 pmRNSHolding(s) in Company
19th Dec 20224:40 pmRNSSecond Price Monitoring Extn
19th Dec 20224:35 pmRNSPrice Monitoring Extension
16th Dec 20221:15 pmRNSDirector/PDMR Shareholding
16th Dec 20221:11 pmRNSDirector/PDMR Shareholding
16th Dec 20221:10 pmRNSDirector/PDMR Shareholding
15th Dec 20227:00 amRNSTrading Update
14th Dec 20224:40 pmRNSSecond Price Monitoring Extn
14th Dec 20224:35 pmRNSPrice Monitoring Extension
9th Dec 20227:00 amRNSDirector/PDMR Shareholding
9th Dec 20227:00 amRNSDirector/PDMR Shareholding
7th Dec 20229:44 amRNSContract Cancellation
6th Dec 20226:29 pmRNSHolding(s) in Company - Replacement
5th Dec 20224:40 pmRNSSecond Price Monitoring Extn
5th Dec 20224:35 pmRNSPrice Monitoring Extension
30th Nov 20227:00 amRNSHalf-year Report
15th Nov 20227:05 amRNSNotice of Interim Results & Investor Presentation
15th Nov 20227:00 amRNSDirectorate Change
7th Nov 20227:00 amRNSBoard Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.